JMERC
Owner
Janbazan Medical and Engineering Research Center (JMERC) is the owner of IJWPH.
0.3
Cite Score
SJR: 0.114 / SNIP: 0.090
Volume 15, Issue 1 (2023)
Iran J War Public Health 2023, 15(1): 1-9 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2021/11/11 | Accepted: 2023/01/15 | Published: 2023/01/30
Received: 2021/11/11 | Accepted: 2023/01/15 | Published: 2023/01/30
How to cite this article
Hadi H, Enayah S. RETN Gene Polymorphisms as a Risk Factor in Diabetic Patients with Covid-19 Infection. Iran J War Public Health 2023; 15 (1) :1-9
URL: http://ijwph.ir/article-1-1060-en.html
URL: http://ijwph.ir/article-1-1060-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Authors
H.S. Hadi *1, S.H. Enayah1
1- Department of Medical Laboratory, Thi-Qar Health Directorate, Thi-Qar, Iraq
Abstract (707 Views)
Aims: People with diabetes mellitus (DM) represent a population group that is at high risk of developing a poor prognosis for Covid-19. Having diabetes increases the risk of serious illness, ICU stay, and death from Covid-19. The present study aimed to determine RETN gene polymorphisms as a risk factor in diabetic patients with Covid-19 infection.
Instruments & Methods: The current study included 150 participants with diabetes, 100 patients of whom had Covid-19 (46 male, 54 female), and 50 had diabetes only (28 male, 22 female). Five ml of venous blood was collected from participants, then used for examining the blood sugar and HbA1c levels and molecular study.
Findings: There was a significant increase in random blood sugar and HbA1C concentrations in diabetic patients infected with Covid-19 compared to diabetic patients only. Regarding the molecular study of the gene encoding the protein resistin, diabetic patients with Covid-19 had a high frequency of single nucleotide polymorphisms compared to diabetic patients only. Polymorphisms of X494T.C, X663A.C, X494T.C, and X663A.C recorded significant differences, while the polymorphisms of rs3219177, X542A.C, and rs3745367 did not show a significant difference.
Conclusion: Diabetic parameters increase in diabetic patients with covid-19 compared to diabetic patients without Covid-19. In addition, diabetic patients with Covid-19 have a high frequency of single nucleotide polymorphisms of the RETN gene.
Instruments & Methods: The current study included 150 participants with diabetes, 100 patients of whom had Covid-19 (46 male, 54 female), and 50 had diabetes only (28 male, 22 female). Five ml of venous blood was collected from participants, then used for examining the blood sugar and HbA1c levels and molecular study.
Findings: There was a significant increase in random blood sugar and HbA1C concentrations in diabetic patients infected with Covid-19 compared to diabetic patients only. Regarding the molecular study of the gene encoding the protein resistin, diabetic patients with Covid-19 had a high frequency of single nucleotide polymorphisms compared to diabetic patients only. Polymorphisms of X494T.C, X663A.C, X494T.C, and X663A.C recorded significant differences, while the polymorphisms of rs3219177, X542A.C, and rs3745367 did not show a significant difference.
Conclusion: Diabetic parameters increase in diabetic patients with covid-19 compared to diabetic patients without Covid-19. In addition, diabetic patients with Covid-19 have a high frequency of single nucleotide polymorphisms of the RETN gene.
References
1. Khan M, Adil SF, Alkhathlan HZ, Tahir MN, Saif S, Khan M, et al. COVID-19: A global challenge with old history, epidemiology and progress so far. Molecules. 2021;26(1):39. [Link] [DOI:10.3390/molecules26010039]
2. Pitlik SD. COVID-19 compared to other pandemic diseases. Rambam Maimonides Med J. 2020;11(3):e0027. [Link] [DOI:10.5041/RMMJ.10418]
3. Habeeb,NJ, Abbas YA, Abass KS, Hussein KR. Detection of Covid-19 (SARS-COV-2) and their virulence factor orf8 gene among patients in Thi-Qar Province, Iraq. Biochem Cell Arch. 2021;21(2):5365-70. [Link]
4. Bhattacharya K, Bhattacharya N, Bhattacharya AS. The discovery of coronavirus-an interesting journey. Galician Med J. 2021;28(3):e202131. [Link] [DOI:10.21802/gmj.2021.3.1]
5. Sultan S, Altayar O, Siddique SM, Davitkov P, Feuerstein JD, Lim JK, et al. aga institute rapid review of the gastrointestinal and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19. Gastroenterology. 2020;159(1):320-34. [Link] [DOI:10.1053/j.gastro.2020.05.001]
6. Zhu Z, Lian X, Su X, Wu W, Marraro GA, Zeng Y. From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res. 2020;21(1):224. [Link] [DOI:10.1186/s12931-020-01479-w]
7. World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. Brazil J Implantol Health Sci. 2020;2(3):173. [Link]
8. 8- Melo-Oliveira ME, Sá-Caputo D, Bachur JA, Paineiras-Domingos LL, Sonza A, Lacerda AC, et al. Reported quality of life in countries with cases of COVID19: a systematic review. Expert Rev Respir Med. 2021;15(2):213-20. [Link] [DOI:10.1080/17476348.2021.1826315]
9. Lv Y, Zhao X, Wang Y, Zhu J, Ma C, Feng X, et al. Abnormal liver function tests were associated with adverse clinical outcomes: an observational cohort study of 2,912 patients with covid-19. Front Med. 2021;8:639855. [Link] [DOI:10.3389/fmed.2021.639855]
10. Akter R, Rahman M, Bhattacharya T, Kaushik D, Mittal V, Parashar J, et al. Novel coronavirus pathogen in humans and animals: an overview on its social impact, economic impact, and potential treatments. Environ Sci Pollut Res Int. 2021;28(48):68071-89. [Link] [DOI:10.1007/s11356-021-16809-8]
11. Sahai A, Bhandari R, Koupenova M, Freedman JE, Godwin M, McIntyre T, et al. SARS-CoV-2 receptors are expressed on human platelets and the effect of aspirin on clinical outcomes in COVID-19 patients. Res Sq. 2020;rs.3.rs-119031. [Link] [DOI:10.21203/rs.3.rs-119031/v1]
12. Moazzami B, Chaichian S, Kasaeian A, Djalalinia S, Akhlaghdoust M, Eslami M, et al. Metabolic risk factors and risk of Covid-19: A systematic review and meta-analysis. PLoS One. 2020;15(12):e0243600. [Link] [DOI:10.1371/journal.pone.0243600]
13. Nassar M, Daoud A, Nso N, Medina L, Ghernautan V, Bhangoo H, et al. Diabetes mellitus and COVID-19. Diabetes Metabo Syndr. 2021;15(6):102268. [Link] [DOI:10.1016/j.dsx.2021.102268]
14. Fazakerley DJ, Krycer JR, Kearney AL, Hocking SL, James DE. Muscle and adipose tissue insulin resistance: malady without mechanism? J Lipid Res. 2019;60(10):1720-32. [Link] [DOI:10.1194/jlr.R087510]
15. Devanoorkar A, Kathariya R, Guttiganur N, Gopalakrishnan D, Bagchi P. Resistin: a potential biomarker for periodontitis influenced diabetes mellitus and diabetes induced periodontitis. Dis Markers. 2014;2014:930206. [Link] [DOI:10.1155/2014/930206]
16. Hivert MF, Manning AK, McAteer JB, Dupuis J, Fox CS, Cupples LA, et al. Association of variants in RETN with plasma resistin levels and diabetes-related traits in the Framingham Offspring Study. Diabetes. 2009;58(3):750-6. [Link] [DOI:10.2337/db08-1339]
17. Al-Harithy RN, Al-Ghamdi S. Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus. Ann Saudi Med. 2005;25(4):283-7. [Link] [DOI:10.5144/0256-4947.2005.283]
18. Zayani N, Hamdouni H, Boumaiza I, Achour O, Neffati F, Omezzine A, et al. Resistin polymorphims, plasma resistin levels and obesity in Tunisian volunteers. J Clin Lab Anal. 2018;32(2):e22227. [Link] [DOI:10.1002/jcla.22227]
19. Sassek M, Pruszynska-Oszmalek E, Kołodziejski PA, Szczepankiewicz D, Kaczmarek P, Wieloch M, et al. Resistin is produced by rat pancreatic islets and regulates insulin and glucagon in vitro secretion. Islets. 2016;8(6):177-85. [Link] [DOI:10.1080/19382014.2016.1251538]
20. Liu SX, Zheng F, Xie KL, Xie MR, Jiang LJ, Cai Y. Exercise reduces insulin resistance in type 2 diabetes mellitus via mediating the lncRNA MALAT1/microRNA-382-3p/resistin axis. Mol Ther Nucleic Acids. 2019;18:34-44. [Link] [DOI:10.1016/j.omtn.2019.08.002]
21. Schwartz DR, Lazar MA. Human resistin: found in translation from mouse to man. Trends Endocrinol Metab. 2011;22(7):259-65. [Link] [DOI:10.1016/j.tem.2011.03.005]
22. Jiang S, Teague AM, Tryggestad JB, Lyons TJ, Chernausek SD. Fetal circulating human resistin increases in diabetes during pregnancy and impairs placental mitochondrial biogenesis. Mol Med. 2020;26(1):76. [Link] [DOI:10.1186/s10020-020-00205-y]
23. Kumar M, Bindu CM, Shyam AC, Reena R. Ferritin-The key model inflammatory marker in diabetic and non-diabetic COVID-19. Asian J Med Sci. 2021;12(12):23-31. [Link] [DOI:10.3126/ajms.v12i12.39717]
24. Codo AC, Davanzo GG, de Brito Monteiro L, de Souza GF, Muraro SP, Virgilio-da-Silva JV, et al. Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis. Cell Metab. 2020;32(3):437-46. [Link] [DOI:10.2139/ssrn.3606770]
25. Smith SM, Boppana A, Traupman JA, Unson E, Maddock DA, Chao K, et al. Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID‐19. J Med Virol. 2021;93(1):409-15. [Link] [DOI:10.1002/jmv.26227]
26. Malik SUF, Chowdhury PA, Hakim A, Islam MS, Alam MJ, Azad AK. Blood biochemical parameters for assessment of COVID-19 in diabetic and non-diabetic subjects: a cross-sectional study. Int J Environ Health Res. 2022;32(6):1344-58. [Link] [DOI:10.1080/09603123.2021.1879741]
27. Reddy PK, Kuchay MS, Mehta Y, Mishra SK. Diabetic ketoacidosis precipitated by COVID-19: a report of two cases and review of literature. Diabetes Metab Syndr. 2020;14(5):1459-62. [Link] [DOI:10.1016/j.dsx.2020.07.050]
28. Chee YJ, Ng SJH, Yeoh E. Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus. Diabetes Res Clin Pract. 2020;164:108166. [Link] [DOI:10.1016/j.diabres.2020.108166]
29. Kim NY, Ha E, Moon JS, Lee YH, Choi EY. Acute hyperglycemic crises with coronavirus disease-19. Diabetes Metab J. 2020;44(2):349-53. [Link] [DOI:10.4093/dmj.2020.0091]
30. Li J, Wang X, Chen J, Zuo X, Zhang H, Deng A. COVID‐19 infection may cause ketosis and ketoacidosis. Diabetes Obes Metab. 2020;22(10):1935-41. [Link] [DOI:10.1111/dom.14057]
31. Lei F, Liu YM, Zhou F, Qin JJ, Zhang P, Zhu L, et al. Longitudinal association between markers of liver injury and mortality in COVID‐19 in China. Hepatology. 2020;72(2):389-98. [Link] [DOI:10.1002/hep.31301]
32. AbdElaleem AAM, Rasheed MM, Hamid HA, Alsayed E, Zanaty MM, Ibrahim AA. Diabetes incidence and impact on mortality with COVID-19 patients. Diabetes. 2022;29(05):1-2. [Link]
33. Chandrashekhar Joshi S, Pozzilli P. COVID-19 induced Diabetes: A novel presentation. Diabetes Res Clin Pract. 2022;191:110034. [Link] [DOI:10.1016/j.diabres.2022.110034]
34. Hayek S, Ben-Shlomo Y, Balicer R, Byrne K, Katz M, Kepten E, et al. Preinfection glycaemic control and disease severity among patients with type 2 diabetes and COVID-19: A retrospective, cohort study. Diabetes Obes Metab. 2021;23(8):1995-2000. [Link] [DOI:10.1111/dom.14393]
35. Holman N, Knighton P, Kar P, O'Keefe J, Curley M, Weaver A, et al. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8(10):823-33. [Link] [DOI:10.1016/S2213-8587(20)30271-0]
36. Yanagisawa S, Oikawa Y, Takagi S, Horikoshi Y, Satomura A, Imai K, et al. HbA1c level may be a risk factor for oxygen therapy requirement in patients with coronavirus disease 2019. J Diabetes Investig. 2022;13(5):909-17. [Link] [DOI:10.1111/jdi.13743]
37. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409(6818):307-12. [Link] [DOI:10.1038/35053000]
38. Sentinelli F, Romeo S, Arca M, Filippi E, Leonetti F, Banchieri M, et al. Human resistin gene, obesity, and type 2 diabetes: mutation analysis and population study. Diabetes. 2002;51(3):860-2. [Link] [DOI:10.2337/diabetes.51.3.860]
39. Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun. 2001;285(2):561-4. [Link] [DOI:10.1006/bbrc.2001.5173]
40. Meizlish ML, Pine AB, Bishai JD, Goshua G, Nadelmann ER, Simonov M, et al. A neutrophil activation signature predicts critical illness and mortality in COVID-19. Blood Adv. 2021;5(5):1164-77. [Link] [DOI:10.1182/bloodadvances.2020003568]
41. Mahase E. Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. BMJ. 2020;368:m641. [Link] [DOI:10.1136/bmj.m641]
42. Sundén-Cullberg J, Nyström T, Lee ML, Mullins GE, Tokics L, Andersson J, et al. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock. Crit Care Med. 2007;35(6):1536-42. [Link] [DOI:10.1097/01.CCM.0000266536.14736.03]
43. Perpiñan C, Bertran L, Terra X, Aguilar C, Binetti J, Lopez-Dupla M, et al. Resistin and IL-15 as predictors of invasive mechanical ventilation in covid-19 pneumonia irrespective of the presence of obesity and metabolic syndrome. J Pers Med. 2022;12(3):391. [Link] [DOI:10.3390/jpm12030391]
44. Nikonovas T, Spessa A, Doerr SH, Clay GD, Mezbahuddin S. Near-complete loss of fire-resistant primary tropical forest cover in Sumatra and Kalimantan. Commun Earth Environ. 2020;1(1):1234567890. [Link] [DOI:10.1038/s43247-020-00069-4]
45. Lin C-Y. Social reaction toward the 2019 novel coronavirus (COVID-19). Soc Health Behav. 2020;3(1):1-2. [Link] [DOI:10.4103/SHB.SHB_11_20]